At the news
? NEUTRALIMPACT 5/10 CLUSTER filed Apr 14, 2026 at 20:00 ET
Three top executives at Bicara Therapeutics, including the CEO, CFO, and President/COO, collectively sold $750K worth of shares in open-market transactions over a 7-day period. These sales coincide with recent option exercises, suggesting planned equity monetization rather than reactive selling.
- CEO Mazumdar Claire sold $354K of shares, following option exercises totaling over $93K in value.
- CFO Hyep Ivan sold $212K of shares, preceded by derivative exercises worth $34.9K.
- President and COO Cohlhepp Ryan sold $184K of shares on April 15.
- Total insider sales: $750K over 7 days, representing 0.05% of the company's $1.5B market cap.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access